DAVE & DUJANOVIC

Utah doctor weighs in on new COVID-19 pill you can take at home

Dec 6, 2021, 4:53 PM | Updated: Aug 2, 2022, 12:35 pm
covid pill...
This undated image provided by Merck & Co. shows their new antiviral medication. The drugmaker has said its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths. (Merck & Co. via AP)
(Merck & Co. via AP)

SALT LAKE CITY — Could the world defeat the pandemic once and for all with a pill everyone could take at home — no doctor’s appointment, no needle necessary? A Utah doctor who specializes in infectious diseases gives her take on a new pill promising to do that.

Independent advisers to the FDA endorsed the pill — molnupiravir — in a 13-to-10 vote last week after voicing concerns about its low efficacy rate and potential risks to pregnant women.

The pill is not meant to replace vaccinations. The Moderna COVID-19 vaccine was 94.1% effective at preventing laboratory-confirmed COVID-19 infection in people who received two doses and had no evidence of being previously infected, according to the CDC.

“The vaccine is our first-line tool for preventing hospitalization, and I’m a little concerned that the attention on molnupiravir will draw attention away from vaccination,” says Yale Medicine infectious diseases specialist Dr. Jaimie Meyer.

Merck said the new pill is 30% effective at reducing the risk of hospitalization and death in high-risk patients, down from the 50% efficacy that Merck announced in October, according to Financial Times.

The pill is meant to be taken after a person has experienced COVID-19 symptoms.

Carlos del Rio, an executive associate dean and infectious disease specialist at the Emory School of Medicine, said the pill “should work” against other variants because of how they stop the virus from replicating as reported by Politico.

The pill structure resembles the nucleosides — or chemical building blocks — used to make the virus’s RNA, which carries the genetic information of many viruses.

The doctor is in

Dr. Emily Spivak is an associate professor of medicine specializing in infectious diseases at the University of Utah Health. She joins KSL NewsRadio’s Debbie Dujanovic and Dave Noriega to talk about the pros and cons of the new pill.

“There are a lot of questions about the effectiveness or efficacy of the drug,” she said. “And that’s one of the reasons that the FDA advisory panel vote was split 13 to 10.”

Spivak pointed out the Merck pill is an anti-viral drug, not a monoclonal antibody in pill form. Some evidence suggests that monoclonal antibody treatment can reduce the amount of virus that causes COVID-19, according to the federal government website Combat Covid

“There is some preliminary evidence that it can incorporate into DNA and cause mutations, specifically in people who are of childbearing reproductive age,” Spivak said.

Proven to work

The new pill is similar to Tamiflu, an antiviral medication used to prevent serious flu symptoms, according to Yale Medicine.

“There’s at least more data in my opinion that Tamiflu actually works. We don’t have one clinical trial thus far for this Merck pill,” Spivak said. “[Tamiflu] doesn’t have these concerns, these really serious side effects — at most it usually makes people nauseated.”

The doctor said she would recommend monoclonal antibody treatment — instead of the Merck pill — for a patent who has risk factors for severe disease.

“At this point, I’m having a hard time thinking of somebody I would recommend the Merck pill for until we have more information.”

Dave & Dujanovic can be heard on weekdays from 9 a.m. to noon. on KSL NewsRadio. Users can find the show on the KSL NewsRadio website and app, as well as Apple Podcasts and Google Play. 

Today’s Top Stories

Dave & Dujanovic

Welcome sign to Moab. A Moab concert series will happen this year....
Allie Litzinger

New ordinance introduced to help in tight housing market in Moab

In an effort to fight a tight Moab housing market, the city has introduced a new ordinance that requires one-third of any new developments be set aside for current employees.
5 days ago
Native American regalia...
Curt Gresseth

U. of U. to offer scholarships to Indigenous students in Utah

The University of Utah announced that scholarships will be offered to members of Utah's eight federally recognized tribes. The university president shares details of the program with Dave & Dujanovic.
5 days ago
BYU study COVID money...
Curt Gresseth

Living paycheck to paycheck? Saving tips as sound as a dollar.

Are you among the 60% of Americans now living paycheck to paycheck. A certified financial planner shares tips on cutting your money waste.
6 days ago
Spc. Jasper Good, of Steamboat Springs, 
Colorado, is one of two Utah National Guard soldiers selec...
Curt Gresseth

Utahns agree: Bring the Olympics (and world) back to Utah

Fraser Bullock, who helped bring the Winter Olympics to Utah in 2002, is trying to do it again in either 2030 or 2034. He talks about the competition and what lies ahead for Utah.
7 days ago
A teacher points to a whiteboard as her students watch. Pandemic learning is still affecting childr...
Samantha Herrera

Study says students are falling behind, showing a decline in math

A new study indicates that the pandemic is still having an effect on students, despite some evidence of a rebound.
7 days ago
One of the signs created by SLC Councilmember Alejandro Puy for neighborhoods in west Salt Lake. (A...
Simone Seikaly

Who is behind the slow down “grandmas at play” signs in Salt Lake?

If you see a sign reading "slow down, Grandmas at play," you'll know you've seen the work of SLC Councilman Alejandro Puy.
7 days ago

Sponsored Articles

Utah doctor weighs in on new COVID-19 pill you can take at home